Results for tag: "Prosthetic Joint Infection Drug"

The Prosthetic Joint Infection Drug market is a subset of the Infectious Diseases Drugs market, focusing on drugs used to treat infections of prosthetic joints. These drugs are typically antibiotics, and are used to treat infections caused by bacteria, fungi, and other microorganisms. The drugs are used to reduce inflammation, pain, and swelling, and to prevent further damage to the joint. They are also used to prevent the spread of infection to other parts of the body. The Prosthetic Joint Infection Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, Johnson & Johnson, Novartis, and Sanofi. Other companies in the market include AstraZeneca, GlaxoSmithKline, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more